PT980263E - Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica - Google Patents

Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica

Info

Publication number
PT980263E
PT980263E PT98928391T PT98928391T PT980263E PT 980263 E PT980263 E PT 980263E PT 98928391 T PT98928391 T PT 98928391T PT 98928391 T PT98928391 T PT 98928391T PT 980263 E PT980263 E PT 980263E
Authority
PT
Portugal
Prior art keywords
nucleic acid
extracellular matrix
defrosting
substance
combination product
Prior art date
Application number
PT98928391T
Other languages
English (en)
Inventor
Serge Braun
Original Assignee
Ass Fr Contre Les Myopathies
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ass Fr Contre Les Myopathies, Transgene Sa filed Critical Ass Fr Contre Les Myopathies
Publication of PT980263E publication Critical patent/PT980263E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT98928391T 1997-05-29 1998-05-29 Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica PT980263E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706600A FR2763958A1 (fr) 1997-05-29 1997-05-29 Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique

Publications (1)

Publication Number Publication Date
PT980263E true PT980263E (pt) 2003-02-28

Family

ID=9507375

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98928391T PT980263E (pt) 1997-05-29 1998-05-29 Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica

Country Status (12)

Country Link
US (1) US6258791B1 (pt)
EP (1) EP0980263B1 (pt)
JP (1) JP2002500662A (pt)
AT (1) ATE224736T1 (pt)
AU (1) AU752146B2 (pt)
CA (1) CA2291590A1 (pt)
DE (1) DE69808274T2 (pt)
DK (1) DK0980263T3 (pt)
ES (1) ES2181234T3 (pt)
FR (1) FR2763958A1 (pt)
PT (1) PT980263E (pt)
WO (1) WO1998053853A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
US7691370B2 (en) 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
WO2000034500A2 (en) * 1998-12-04 2000-06-15 Genzyme Corporation Methods for increasing the efficiency of gene transfer
ATE245452T1 (de) * 1998-12-23 2003-08-15 Esparma Gmbh Hyaluronatlyase als penetrationsförderer in topischen mitteln
IL152420A0 (en) * 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
EP1467768A1 (en) * 2001-11-26 2004-10-20 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Increasing electro-gene transfer of nucleic acid molecules into host tissue
US7144870B2 (en) 2002-02-15 2006-12-05 Research Development Foundation Hyaluronic acid mediated adenoviral transduction
DE10211457A1 (de) * 2002-03-12 2003-09-25 Knoell Hans Forschung Ev Verwendung von Hyaluronatlyase zur Behandlung von Myokardinfarkten
EP1521523A4 (en) * 2002-05-20 2006-04-19 Univ Texas METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS
WO2004098534A2 (en) * 2003-02-24 2004-11-18 Therion Biologics Corporation Methods for delivering angiogenic modulators using pox viruses
WO2004078140A2 (en) 2003-03-05 2004-09-16 Halozyme, Inc. SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
US20050014714A1 (en) * 2003-06-04 2005-01-20 The Johns Hopkins University Gene delivery to organs
WO2005014642A2 (en) 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
US7888201B2 (en) * 2003-11-04 2011-02-15 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor-on-insulator SRAM configured using partially-depleted and fully-depleted transistors
US7572613B2 (en) * 2004-06-25 2009-08-11 Klein Jeffrey A Drug delivery system for accelerated subcutaneous absorption
JP2007175021A (ja) * 2005-12-28 2007-07-12 Sysmex Corp 大腸がんのリンパ節転移マーカー
EP2117584B1 (en) * 2007-02-15 2013-10-09 Allergan, Inc. Use of botulinum toxin and enzymes for treating bladder disorders
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
WO2010138918A1 (en) * 2009-05-29 2010-12-02 Pacira Pharmaceuticals, Inc. Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
ES2770575T3 (es) 2010-10-28 2020-07-02 Pacira Pharmaceuticals Inc Formulación de liberación sostenida de un fármaco antiinflamatorio no esteroideo
WO2014066443A1 (en) 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
JP7078620B2 (ja) 2016-11-16 2022-05-31 イミュノミック セラピューティックス， インコーポレイテッド アレルギーの治療のための核酸
CN109983013A (zh) 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
WO2018195527A1 (en) 2017-04-22 2018-10-25 Immunomic Therapeutics, Inc. Improved lamp constructs
KR20240027895A (ko) 2017-05-02 2024-03-04 이뮤노믹 쎄라퓨틱스, 인크. 암 항원을 포함하는 lamp (리소솜 연관 막 단백질) 구축물
JP2021523185A (ja) 2018-05-15 2021-09-02 イミュノミック セラピューティックス， インコーポレイテッドＩｍｍｕｎｏｍｉｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． アレルゲンを含む改善されたｌａｍｐ構築物
AU2020366515A1 (en) 2019-10-18 2022-04-21 Immunomic Therapeutics, Inc. Improved lamp constructs comprising cancer antigens
US20220401583A1 (en) * 2021-06-16 2022-12-22 BioViva USA, Inc. Treatment of age-related cognitive decline using genetically modified viral vectors
WO2023201201A1 (en) 2022-04-10 2023-10-19 Immunomic Therapeutics, Inc. Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012329A2 (en) * 1990-02-12 1991-08-22 Board Of Regents, The University Of Texas System Satellite cell proliferation in adult skeletal muscle
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
US5739118A (en) * 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
FR2732895B1 (fr) 1995-04-11 1997-05-16 Pasteur Merieux Serums Vacc Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
US5858351A (en) 1996-01-18 1999-01-12 Avigen, Inc. Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer

Also Published As

Publication number Publication date
FR2763958A1 (fr) 1998-12-04
EP0980263A1 (fr) 2000-02-23
AU752146B2 (en) 2002-09-05
ATE224736T1 (de) 2002-10-15
CA2291590A1 (fr) 1998-12-03
JP2002500662A (ja) 2002-01-08
DK0980263T3 (da) 2003-02-03
US6258791B1 (en) 2001-07-10
WO1998053853A1 (fr) 1998-12-03
EP0980263B1 (fr) 2002-09-25
ES2181234T3 (es) 2003-02-16
DE69808274D1 (de) 2002-10-31
DE69808274T2 (de) 2003-05-15
AU8023898A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
PT980263E (pt) Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica
ATE313642T1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
AU2821297A (en) In vivo gene transfer methods for wound healing
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
MX9700270A (es) Composicion que contiene acidos nucleicos, preparacion y utilizacion.
BR9810372A (pt) Processo de transferência de ácido nucléico para o interior de células de organismos eucarióticos pluricelulares in vivo, composição, ácido nucléico e campo elétrico, e, produto de combinação
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
BR9714513A (pt) Genes que codificam para aminoácido-deacetilases com especificidade para n-acetil-l-fosfinotricina, seu isolamento e emprego
BR0010220A (pt) Compostos de pirimidinona
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
HUP0001937A2 (hu) Új vegyületek, eljárás előállításukra és alkalmazásuk nukleinsavak sejtekbe való bevitelére
BR0309127A (pt) Composição para proliferação de células
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
BR0014519A (pt) Sequências de sinais para a preparação de leu-herudin através da secreção por e. coli no meio de cultura
BR0011322A (pt) Composições que afetam a morte programada de células e seu uso na modificação do desenvolvimento de plantas florestais
NO20003880L (no) Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser
AU6193699A (en) Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1
Whitehead et al. EaeI: a restriction endonuclease from Enterobacter aerogenes
BR9808554A (pt) Esterase do ácido fenólico e o uso da mesma
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
SE0202253D0 (sv) Novel sequence information and methods for its use in diagnosis and therapy XIII
HUP0102455A2 (hu) Új nukleinsav-transzfer ágensek, ezeket tartalmazó készítmények és alkalmazásuk
BR0111228A (pt) Processo para ligar um antìgeno a uma molécula, e, sistema de ministração visada